Načítá se...
What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
PURPOSE OF REVIEW: We highlight the unique properties of the sodium-glucose cotransporter-2 (SGLT-2 inhibitors) which may lend favorably to their efficient integration in the background of other heart failure (HF) therapies. We also discuss the unique aspects of SGLT-2 inhibitor dosing, lack of titr...
Uloženo v:
| Vydáno v: | Curr Diab Rep |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7548057/ https://ncbi.nlm.nih.gov/pubmed/33040170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11892-020-01347-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|